Binh Dinh Pharmaceutical And Medical Equipment JSC (STC:DBD) 3-Year RORE % : 3.09% (As of Mar. 2026)


STC:DBD Binh Dinh Pharmaceutical And Medical Equipment JSC STC:DBD
83 GF Score
Price ₫51,400.00
GF Value ₫52,300.50
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Binh Dinh Pharmaceutical And Medical Equipment JSC 3-Year RORE %?

Binh Dinh Pharmaceutical And Medical Equipment JSC STC:DBD +0.39% 83 3-Year RORE % is 3.09 as of Mar. 2026. GuruFocus rates STC:DBD with a GF Score™ of 83/100 and a GF Value™ of ₫52,300.50 (Fairly Valued). The stock has 3 warning signs investors should review. Among 936 Drug Manufacturers companies, Binh Dinh Pharmaceutical And Medical Equipment JSC ranks better than 50.21% on this metric.

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. Binh Dinh Pharmaceutical And Medical Equipment JSC's 3-Year RORE % for the quarter that ended in Mar. 2026 was 3.09%.

The industry rank for Binh Dinh Pharmaceutical And Medical Equipment JSC's 3-Year RORE % or its related term are showing as below:

STC:DBD's 3-Year RORE % is ranked better than
50.21% of 936 companies
in the Drug Manufacturers industry
Industry Median: 3.075 vs STC:DBD: 3.09

Binh Dinh Pharmaceutical And Medical Equipment JSC  (STC:DBD) 3-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


Binh Dinh Pharmaceutical And Medical Equipment JSC 3-Year RORE % Related Terms


Binh Dinh Pharmaceutical And Medical Equipment JSC 3-Year RORE % Historical Data

* Premium members only.

The historical data trend for Binh Dinh Pharmaceutical And Medical Equipment JSC's 3-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Binh Dinh Pharmaceutical And Medical Equipment JSC 3-Year RORE % Chart

Binh Dinh Pharmaceutical And Medical Equipment JSC Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
3-Year RORE %
Get a 7-Day Free Trial 13.92 18.70 14.61 14.64 20.75

Binh Dinh Pharmaceutical And Medical Equipment JSC Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
3-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 25.58 32.69 25.29 20.75 3.09

STC:DBD vs ZTS, UTHR: 3-Year RORE % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Binh Dinh Pharmaceutical And Medical Equipment JSC's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Binh Dinh Pharmaceutical And Medical Equipment JSC 3-Year RORE % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Binh Dinh Pharmaceutical And Medical Equipment JSC's 3-Year RORE % distribution charts can be found below:

* The bar in red indicates where Binh Dinh Pharmaceutical And Medical Equipment JSC's 3-Year RORE % falls into.


STC:DBD
83GF Score
Binh Dinh Pharmaceutical And Medical Equipment JSC STC:DBD
3-Year RORE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Binh Dinh Pharmaceutical And Medical Equipment JSC 3-Year RORE % Calculation

Binh Dinh Pharmaceutical And Medical Equipment JSC's 3-Year RORE % for the quarter that ended in Mar. 2026 is calculated as:

3-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 3-year -Cumulative Dividends per Share for 3-year )
=( 3079.077-2862.166 )/( 9030.839-2000 )
=216.911/7030.839
=3.09 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Mar. 2026 and 3-year before.

Frequently Asked Questions Learn more about 3-Year RORE % →
What does a 3-Year RORE % of 3.09 mean?
Binh Dinh Pharmaceutical And Medical Equipment JSC (STC:DBD) has a 3-Year RORE % of 3.09 as of Mar. 2026. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Binh Dinh Pharmaceutical And Medical Equipment JSC and its competitors. According to the industry distribution chart, Binh Dinh Pharmaceutical And Medical Equipment JSC ranks #466 out of 936 companies in the Drug Manufacturers industry, placing it in the top 49.8%.
Is Binh Dinh Pharmaceutical And Medical Equipment JSC's 3-Year RORE % too high?
Binh Dinh Pharmaceutical And Medical Equipment JSC's current 3-Year RORE % is 3.09. The Drug Manufacturers industry median 3-Year RORE % is 3.08. Binh Dinh Pharmaceutical And Medical Equipment JSC's value of 3.09 is 0.5% above this industry median. Based on the distribution chart, Binh Dinh Pharmaceutical And Medical Equipment JSC ranks #466 out of 936 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Binh Dinh Pharmaceutical And Medical Equipment JSC has a GF Score™ of 83/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Binh Dinh Pharmaceutical And Medical Equipment JSC's 3-Year RORE % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Binh Dinh Pharmaceutical And Medical Equipment JSC ranks #466 out of 936 companies for 3-Year RORE %. This puts Binh Dinh Pharmaceutical And Medical Equipment JSC in the upper half of its industry. The industry median 3-Year RORE % is 3.08. Binh Dinh Pharmaceutical And Medical Equipment JSC's value of 3.09 is 0.5% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year RORE % for a Drug Manufacturers company?
The median 3-Year RORE % among Drug Manufacturers companies is 3.08, based on 936 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year RORE % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Binh Dinh Pharmaceutical And Medical Equipment JSC's current 3-Year RORE % of 3.09 is 0.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year RORE % mean?
A high 3-Year RORE % can signal that a stock is expensive relative to its fundamentals. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Binh Dinh Pharmaceutical And Medical Equipment JSC and its competitors. For the Drug Manufacturers industry, the median 3-Year RORE % is 3.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Binh Dinh Pharmaceutical And Medical Equipment JSC's current 3-Year RORE % is 3.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Binh Dinh Pharmaceutical And Medical Equipment JSC stock overvalued right now?
Based on GuruFocus' analysis, Binh Dinh Pharmaceutical And Medical Equipment JSC (STC:DBD) is currently considered Fairly Valued. The stock's GF Value™ is ₫52,300.50, compared to a current price of ₫51,400.00 — trading 1.7% below its estimated fair value. The current 3-Year RORE % is 3.09 and 0.5% above the Drug Manufacturers industry median of 3.08. Binh Dinh Pharmaceutical And Medical Equipment JSC's overall GF Score™ is 83/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year RORE % calculated?
3-Year RORE % is calculated from a company's financial statements. For Binh Dinh Pharmaceutical And Medical Equipment JSC (STC:DBD), the current 3-Year RORE % is 3.09 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Binh Dinh Pharmaceutical And Medical Equipment JSC (STC:DBD) Overvalued in 2026?

Based on GuruFocus' analysis, Binh Dinh Pharmaceutical And Medical Equipment JSC stock appears to be undervalued. The current stock price of ₫51,400.00 is trading 1.7% below its estimated GF Value™ of ₫52,300.50. GuruFocus considers Binh Dinh Pharmaceutical And Medical Equipment JSC to be Fairly Valued.

Key valuation signals for STC:DBD:

  • 3-Year RORE %: 3.09
  • GF Value™: ₫52,300.50 vs. price of ₫51,400.00 (1.7% below fair value)
  • GF Score™: 83/100 with 3 warning signs
  • Industry Position: 0.5% above the Drug Manufacturers median (#466 of 936)

No single metric tells the full story. See the STC:DBD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Binh Dinh Pharmaceutical And Medical Equipment JSC Business Description

Address 498 Nguyen Thai Hoc Street, Quang Trung Ward, Binh Dinh Province, Quy Nhon, VNM
Binh Dinh Pharmaceutical And Medical Equipment JSC is a pharmaceutical company. The company is engaged in production and trade of pharmaceutical products, medicinal herbs, pharmaceutical and medical equipment.
83GF Score

Get the complete analysis for STC:DBD

3-Year RORE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₫51,400.00
Price
₫52,300.50
GF Value